6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

July 21, 2008

Commission File Number 001-14956

BIOVAIL CORPORATION

(Translation of Registrant’s name into English)

7150 Mississauga Road, Mississauga, Ontario, CANADA, L5N 8M5

(Address of principal executive office and zip code)

Registrant’s telephone number, including area code: (905) 286-3000

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x                        Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1).

Yes o                       No x

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7).

Yes o                        No x

Indicate by check mark whether by furnishing the information contained in this form the registrant is also hereby furnishing the information to the Commission pursuant to Rule 12g 3-2(b) under the Securities Exchange Act of 1934.

Yes o                       No x

BIOVAIL CORPORATION

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the registration statements on Form S-8 (Registration Nos. 333-92229 and 333-138697) of Biovail Corporation.

INDEX

Exhibit 99.1            Notice of Reconvened Annual Meeting of  Shareholders

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Biovail Corporation
Date: July 21, 2008	By:	/ s / Jennifer Tindale
		Jennifer Tindale
		Vice President &
		Associate General Counsel

2

EX-99.1

Exhibit 99.1

NOTICE OF RECONVENED ANNUAL MEETING OF SHAREHOLDERS

Notice is hereby given that the Annual Meeting of Shareholders (the “Meeting”) of Biovail Corporation (the “Company” or “Biovail”), which was adjourned on June 25, 2008, will be reconvened:

Date:	Friday, the 8th day of August, 2008
Time:	10:00 a.m. (Toronto time)
Place:	InterContinental Toronto Centre Hotel
	225 Front Street West
	Toronto, ON M5V 2X3

Business of the Meeting:

·to receive the audited comparative consolidated financial statements of the Company as at and for the fiscal year ended December 31, 2007 and the auditors’ report thereon, a copy of which was enclosed with the Company’s Management Proxy Circular dated May 9, 2008;

·to elect directors for the ensuing year;

·to re-appoint Ernst & Young LLP as auditors for the ensuing year and authorize the Board of Directors to fix the auditors’ remuneration; and

to transact such other business as may properly be brought before the Meeting.

The specific details of the foregoing matters to be put before the Meeting are set forth in the Proxy Circulars which were previously mailed to shareholders by Biovail and by Eugene Melnyk and EM Holdings B.V. (the “Dissident Shareholders”).

The record date for the Meeting, April 28, 2008, remains unchanged. Shareholders of record at the close of business on April 28, 2008 will be entitled to vote at the Meeting.

Shareholders are invited to attend the Meeting. If you have not yet submittedyour proxy, you can still vote either of the forms of proxy previouslyprovided to you by Biovail or the Dissident Shareholders. Registeredshareholders who are unable to attend the Meeting in person are urged to voteusing any one of the methods outlined on those proxy forms, including mail,facsimile, telephone or Internet. Non-registered shareholders who receivethese materials through their broker or other intermediary should follow theinstructions provided by their broker or intermediary. To be effective, yourproxy must be received by CIBC Mellon Trust Company not later than 10:00a.m. (Toronto time) on August 6, 2008, or in the case of any furtheradjournment of the Meeting, not less than 48 hours, Saturdays, Sundays andholidays excepted, prior to the time of the adjournment. The time limit fordeposit of proxies may be waived by Biovail’s Board of Directors at itsdiscretion without notice. Completing and sending a new proxy will cancelany other proxy you may have previously submitted, as it is the later datedproxy that will be counted.

If you are a holder of Biovail common shares that you did not hold on theApril 28, 2008 record date and you wish to vote such shares, you shouldcontact the vendor who held the shares as at April 28, 2008 in order to seek tomake arrangements to permit you to vote such shares at the Meeting.

You may revoke any proxy that you have given. In addition to revocation inany other manner permitted by law, you may revoke the proxy by preparing awritten statement, signed by you or your attorney, or if the proxy is given onbehalf of a corporation, by an authorized officer or attorney of suchcorporation, and depositing such written revocation statement at the office ofCIBC Mellon at any time up to and including the last business day precedingthe day of the Meeting (or any adjournment thereof) at which the proxy is tobe used, or with the Chairman of the Meeting on the day of the Meeting (orany adjournment thereof) prior to the proxy being voted.

DATED at Mississauga, Ontario this 17th day of July, 2008.

By Order of the Board of Directors

/s/ Wendy A. Kelley

Wendy A. Kelley

Senior Vice-President, General Counsel and

Corporate Secretary